Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Cancer Cell|August 15, 2018
Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and InvasionRamona Schulz-Heddergott, Nadine Stark, Shelley J Edmunds, et al.Gastroenterology|November 19, 2022
Loss of SUV420H2-Dependent Chromatin Compaction Drives Right-Sided Colon Cancer ProgressionVerawan Boonsanay, Mohammed H Mosa, Mario Looso, et al.Immunity|March 1, 2025
IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesisDominic Denk, Mallika Ramakrishnan, Claire Conche, et al.Gut|January 27, 2023
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockadeClaire Conche, Fabian Finkelmeier, Marina Pešić, et al.Cell Reports|September 23, 2014
PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cellsSimone Ragusa, Jianpin Cheng, Konstantin I Ivanov, et al.Nature|August 4, 2017
Corrigendum: Modulating the therapeutic response of tumours to dietary serine and glycine starvationOliver D K Maddocks, Dimitris Athineos, Eric C Cheung, et al.Nature|April 21, 2017
Modulating the therapeutic response of tumours to dietary serine and glycine starvationOliver D K Maddocks, Dimitris Athineos, Eric C Cheung, et al.Nature|November 17, 2022
Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulationMark Schmitt, Fatih Ceteci, Jalaj Gupta, et al.Cancer Discovery|March 4, 2018
Colorectal Tumors Require NUAK1 for Protection from Oxidative StressJennifer Port, Nathiya Muthalagu, Meera Raja, et al.The EMBO Journal|August 5, 2015
E-cadherin can limit the transforming properties of activating β-catenin mutationsDavid J Huels, Rachel A Ridgway, Sorina Radulescu, et al.Pageof 3